References
- Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use in primary health care. Ann Rheum Dis 2001;60:91–7
- Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888–99
- Psaty BM, Furberg CD. Cox-2 inhibitors. Lessons in drug safety. N Engl J Med 2005;352:1133–5
- Balazs EA, Watson D, Duff IF, et al. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 1967;10:357–75
- Balazs EA, Denlinger JL. Sodium hyaluronate and joint function. J Equine Vet Sci 1985;5:217–28
- Balazs EA, Denlinger JL. Clinical uses of hyaluronan. In: Evered D, Whelan J, editors. The biology of hyaluronan (Ciba Foundation Symposium no. 143), Chichester/New York: John Wiley, 1989, pp.265–80
- Pham T, Le Henanff A, Ravaud P, et al. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis 2004;63:1611–7
- Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 2004;22:300–6
- Day R, Brooks P, Conaghan PG, et al. Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. J Rheumatol 2004;31:75–82
- Kahan A, Lleu PL, Salin L. Prospective randomized study comparing the medicoeconomic benefits of Hylan GF-20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003;70: 276–81
- Tasciotaoglu F, Oner C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003;22:112–7
- Bellamy N, Campbell J, Robinson V, et al. Visco-supplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005;CD005321
- Arrich J, Piribauer F, Mad P, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172:1039–43
- Stucki G, Meier D, Stucki S, et al. Evaluation einer deutschen Version des WOMAC (Western Ontario und McMaster Universities) Arthroseindex. Z Rheumatol 1996;55:40–9
- Bjordal JM, Ljunggren AE, Klovning A, et al. Non-steroidal antiinflammatory drugs, including COX-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 2004;329:1317
- Balazs EA. Viscoelastic properties of hyaluronic acid and biological lubrication. Univ Mich Med Ctr J 1968(Suppl):255–9
- Balazs EA. The physical properties of synovial fluid and the special role of hyaluronic acid. In: Helfet A, editor. Disorders of the knee. 2nd edn. Philadelphia: JB Lippincott, 1982, pp.61–74
- Balazs EA, Denlinger JL. The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron JG, editor. Osteoarthritis – current clinical and fundamental problems. Rueil-Malmaison: Laboratoires Ciba-Geigy, 1985, pp.165–174
- Balazs EA, Denlinger JL. Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol 1993;20 (Suppl 39):3–9
- Jones A, Regan M, Ledingham J, et al. Importance of placement of intra-articular steroid injections. British Med J 1993;307:1329–40
- McDonald C, Hantel S, Strohmeier M. A randomised, controlled study to compare the performance and safety of two sources of sodium hyaluronate given as a viscosupplement by intra-articular injection to patients with osteoarthritis of the knee. J Clin Res 2000;3:41–50
- Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with Hylan for the treatment of osteoarthritis: Findings from clinical practice in Canada. J Rheumatol 1996;23:1579–85